RASSF1 and hepatocellular carcinoma: Combining LINE-1 hypomethylation with other epigenetic markers, such as RASSF1A hypermethylation in HCC or AIM1 methylation in melanoma, has further enhanced prognostic accuracy and predicted early recurrence after surgery.